Doctors regularly warn their patients that having high levels of triglycerides, a major dietary fat, can increase the risk of heart disease, diabetes, obesity, and fatty liver disease. There is considerable interest in finding novel ways to effectively regulate triglycerides in the blood to help manage these potentially life-threatening common conditions.

Now, researchers have discovered the 3D structure and function of diacylglycerol O-acyltransferase-1 (DGAT1), the enzyme that synthesizes triglycerides and is also required for human dietary fat absorption and storage. DGAT1 is a known target to treat obesity and other metabolic diseases, so having a detailed understanding of what DGAT1 looks like and how it works opens opportunities for designing novel strategies for managing these conditions. The findings were published today in Nature.

“DGAT1 is a particularly interesting enzyme because it synthesizes triglycerides, which are the main component of hard fat, the type of fat usually found in the belly or midsection in our body. Triglycerides also are part of the particles that transport cholesterol—high-density lipoproteins (HDL, or ‘good cholesterol’), and low-density and very-low-density lipoproteins (LDL and VLDL, or ‘bad cholesterols’),” says co-corresponding author Ming Zhou of BCM. “Learning to regulate this enzyme can help regulate fat synthesis and potentially manage related conditions.”

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

The team applied cryo-electron microscopy, a technique that enables scientists to see how biomolecules move and interact as they perform their functions, to visualize the 3D structure of DGAT1. “This project was challenging because DGAT1 is embedded in biological membranes where it carries its function,” says first author Lie Wang, also of BCM. “We also developed an enzymatic assay, or test, to monitor the activity of DGAT1 in real time. Thanks to the integration of high-quality structure and precise functional studies, we were able to unveil the structure of this important enzyme and gain novel insights into the mechanism of action.”

DGAT1 is located in the membrane of the endoplasmic reticulum, a cellular structure engaged in the synthesis of proteins and lipids.

“It was exciting to discover that DGAT1 forms a large chamber inside the membrane, which was unexpected,” Wang says. “This ‘reaction chamber’ isolates a space within the membrane where the enzymatic synthesis of triglycerides takes place.”

“The reactants meet inside the chamber and that is where the reaction occurs,” Zhou adds. “Then, the triglycerides bud-off the membrane in lipid droplets that carry them to where they are needed in the cell.”